FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4377011034> ?p ?o ?g. }

• W4377011034 endingPage "786" @default.
• W4377011034 startingPage "778" @default.
• W4377011034 abstract "Abstract Study Objective Acute kidney injury (AKI) is a common and serious complication after coronary artery bypass grafting (CABG) surgery. Patients with diabetes are commonly associated with renal microvascular complications and have a greater risk of AKI after CABG surgery. This study aimed to explore whether preoperative metformin administration could reduce the incidence of postoperative AKI following CABG in patients with type 2 diabetes. Design Patients with diabetes who underwent CABG were retrospectively included in this study. AKI after CABG was defined according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria. The effects of metformin on postoperative AKI following CABG in patients were compared and analyzed. Data Source Patients were enrolled in this study between January 2019 and December 2020 in Beijing Anzhen Hospital. Patients A total of 812 patients were enrolled. The patients were divided into the metformin group (203 cases) and the control group (609 cases) according to whether metformin was used preoperatively. Intervention Inverse probability of treatment weighting (IPTW) was applied to minimize baseline differences between the two groups. IPT‐weighted p values were analyzed to evaluate the postoperative outcomes between the two groups. Measurements and Main Results The incidence of AKI in the metformin group and the control group was compared. After IPTW adjustment, the incidence of AKI in the metformin group was lower than the control group (IPTW‐adjusted p < 0.001). In the subgroup analysis, metformin showed significant protective effects in the estimated glomerular filtration rate (eGFR) < 60 mL/min per 1.73 m 2 and eGFR 60–90 mL/min per 1.73 m 2 subgroups, which was not observed in the eGFR ≥90 mL/min per 1.73 m 2 subgroup. No significant differences in the incidence of renal replacement therapy, reoperation due to bleeding, in‐hospital mortality, or red blood cell transfusion volume were observed between the two groups. Conclusions In this study, we provided evidence that preoperative metformin was associated with a significant reduction of postoperative AKI following CABG in patients with diabetes. Metformin showed significant protective effects in patients with mild‐to‐moderate renal insufficiency." @default.
• W4377011034 created "2023-05-19" @default.
• W4377011034 creator A5018630603 @default.
• W4377011034 creator A5019944916 @default.
• W4377011034 creator A5055613862 @default.
• W4377011034 creator A5069352060 @default.
• W4377011034 creator A5081101454 @default.
• W4377011034 date "2023-06-01" @default.
• W4377011034 modified "2023-10-17" @default.
• W4377011034 title "Metformin use is associated with reduced acute kidney injury following coronary artery bypass grafting in patients with type 2 diabetes: An inverse probability of treatment weighting analysis" @default.
• W4377011034 cites W1928590661 @default.
• W4377011034 cites W1964047089 @default.
• W4377011034 cites W1973768018 @default.
• W4377011034 cites W1974757312 @default.
• W4377011034 cites W1976509351 @default.
• W4377011034 cites W1997877914 @default.
• W4377011034 cites W2052410694 @default.
• W4377011034 cites W2085849057 @default.
• W4377011034 cites W2098961381 @default.
• W4377011034 cites W2110818436 @default.
• W4377011034 cites W2136378121 @default.
• W4377011034 cites W2164639052 @default.
• W4377011034 cites W2222574236 @default.
• W4377011034 cites W2292559204 @default.
• W4377011034 cites W2467227824 @default.
• W4377011034 cites W2570191103 @default.
• W4377011034 cites W2576163065 @default.
• W4377011034 cites W2589009607 @default.
• W4377011034 cites W2600792635 @default.
• W4377011034 cites W2604467988 @default.
• W4377011034 cites W2605479507 @default.
• W4377011034 cites W2606423330 @default.
• W4377011034 cites W2615714795 @default.
• W4377011034 cites W2616446856 @default.
• W4377011034 cites W2738675792 @default.
• W4377011034 cites W2751869644 @default.
• W4377011034 cites W2757040979 @default.
• W4377011034 cites W2800681892 @default.
• W4377011034 cites W2806465873 @default.
• W4377011034 cites W2891305688 @default.
• W4377011034 cites W2895524980 @default.
• W4377011034 cites W2913071778 @default.
• W4377011034 cites W2914902752 @default.
• W4377011034 cites W2916667086 @default.
• W4377011034 cites W2951853690 @default.
• W4377011034 cites W2963983341 @default.
• W4377011034 cites W2966594136 @default.
• W4377011034 cites W3009389584 @default.
• W4377011034 cites W3027020270 @default.
• W4377011034 cites W3035760979 @default.
• W4377011034 cites W3048613645 @default.
• W4377011034 cites W3202635208 @default.
• W4377011034 cites W4212810717 @default.
• W4377011034 doi "https://doi.org/10.1002/phar.2827" @default.
• W4377011034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37199291" @default.
• W4377011034 hasPublicationYear "2023" @default.
• W4377011034 type Work @default.
• W4377011034 citedByCount "0" @default.
• W4377011034 crossrefType "journal-article" @default.
• W4377011034 hasAuthorship W4377011034A5018630603 @default.
• W4377011034 hasAuthorship W4377011034A5019944916 @default.
• W4377011034 hasAuthorship W4377011034A5055613862 @default.
• W4377011034 hasAuthorship W4377011034A5069352060 @default.
• W4377011034 hasAuthorship W4377011034A5081101454 @default.
• W4377011034 hasConcept C120665830 @default.
• W4377011034 hasConcept C121332964 @default.
• W4377011034 hasConcept C126322002 @default.
• W4377011034 hasConcept C134018914 @default.
• W4377011034 hasConcept C141071460 @default.
• W4377011034 hasConcept C159641895 @default.
• W4377011034 hasConcept C167135981 @default.
• W4377011034 hasConcept C2777180221 @default.
• W4377011034 hasConcept C2780323712 @default.
• W4377011034 hasConcept C2780472472 @default.
• W4377011034 hasConcept C555293320 @default.
• W4377011034 hasConcept C61511704 @default.
• W4377011034 hasConcept C71924100 @default.
• W4377011034 hasConceptScore W4377011034C120665830 @default.
• W4377011034 hasConceptScore W4377011034C121332964 @default.
• W4377011034 hasConceptScore W4377011034C126322002 @default.
• W4377011034 hasConceptScore W4377011034C134018914 @default.
• W4377011034 hasConceptScore W4377011034C141071460 @default.
• W4377011034 hasConceptScore W4377011034C159641895 @default.
• W4377011034 hasConceptScore W4377011034C167135981 @default.
• W4377011034 hasConceptScore W4377011034C2777180221 @default.
• W4377011034 hasConceptScore W4377011034C2780323712 @default.
• W4377011034 hasConceptScore W4377011034C2780472472 @default.
• W4377011034 hasConceptScore W4377011034C555293320 @default.
• W4377011034 hasConceptScore W4377011034C61511704 @default.
• W4377011034 hasConceptScore W4377011034C71924100 @default.
• W4377011034 hasIssue "8" @default.
• W4377011034 hasLocation W43770110341 @default.
• W4377011034 hasLocation W43770110342 @default.
• W4377011034 hasOpenAccess W4377011034 @default.
• W4377011034 hasPrimaryLocation W43770110341 @default.
• W4377011034 hasRelatedWork W2017470589 @default.
• W4377011034 hasRelatedWork W2080042754 @default.
• W4377011034 hasRelatedWork W2105403615 @default.

• next